SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending due to its robust earnings and optimistic outlook, confirming strong demand for AI and accelerated computing platforms. However, community discussion centers on the stock's muted price reaction despite the impressive results, with speculation ranging from market manipulation impacting options to ongoing debates about the sustainability of the AI boom versus an overvalued market.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Its shares are plummeting after Q1 revenue guidance fell short of analyst expectations despite a Q4 beat, fueling a community debate over whether the sell-off is an extreme overreaction to a minor miss or indicative of fundamental challenges and leadership concerns.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

A new $50 billion share buyback authorization is driving significant conversation around Salesforce, with investors sharply divided on whether it signals deep undervaluation and future EPS growth or a defensive maneuver against widespread AI disruption concerns in the software sector.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is trending with significant momentum following an impressive earnings blowout that exceeded expectations and strong 2026 revenue guidance, which is further bolstered by the company securing a spot on a major multi-billion dollar defense contract, prompting community discussion around a potential short squeeze.

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

Larimar Therapeutics is soaring after its Friedreich's ataxia treatment received FDA Breakthrough Therapy Designation, igniting strong investor optimism for accelerated approval and high valuations. However, an upsized public offering at $5.00 is simultaneously sparking intense debate among traders regarding dilution versus strategic funding for commercialization.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is surging after boosting its profit outlook and unveiling significant share buyback plans, exciting the community about its accelerated financial turnaround and strong growth prospects in civil aerospace, defense, and SMR-driven power systems.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is gaining attention ahead of its Q4 earnings, as investors anticipate strong results, profitability signals, and a potential short squeeze, fueled by the launch of new Sales Assist AI agents and strategic expansion into India, amplified by the positive sentiment from NVIDIA's broader AI narrative.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy is seeing heightened attention ahead of its anticipated earnings report, with recent positive news around its Indensity battery architecture and a significant 400 MWh Texas battery project fueling discussion. The community is sharply divided on whether the company will deliver strong financials and guidance after past misses, while many highlight its long-term potential in the rapidly growing energy storage sector, especially in light of increasing power demands from AI data centers.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending on high anticipation for its imminent earnings report, fueled by optimistic projections for increased shelf space and Alani Nu's robust growth, though some in the community remain wary of past "noise" from management and speculate on a potential PepsiCo buyout strategy.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

CRCL is seeing significant upward momentum following a strong Q4 earnings report that revealed substantial growth in USDC circulation and transaction volume. The community is actively discussing its potential as a core digital financial infrastructure for stablecoin transactions and AI agents, alongside short squeeze speculation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Xenon Pharmaceuticals (NASDAQ:XENE) Upgraded at Wolfe Research

Wolfe Research upgraded shares of Xenon Pharmaceuticals to a "strong-buy" rating in a research report on Monday...

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Consensus Recommendation of "Buy" from Analysts

Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) has been given a consensus rating of "Buy" by the thirteen brokerages that are covering the company, MarketBeat reports. One research...

Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data

Key PointsConnecticut-based Braidwell sold 1,779,953 Xenon Pharmaceuticals shares in the fourth quarter; the estimated transaction value was $74.76 million based on quarterly average prices...

Xenon Pharmaceuticals (XENE) Projected to Post Earnings on Thursday

Xenon Pharmaceuticals (NASDAQ:XENE) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...

Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE)

Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) was the target of unusually large options trading on Wednesday. Stock traders acquired 4,063 put options on the company. This represents an...

Aberdeen Group plc Has $23.25 Million Holdings in Xenon Pharmaceuticals Inc. $XENE

Aberdeen Group plc increased its holdings in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) by 11.1% during the third quarter, according to the company in its most recent 13F filing...

Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) has received an average rating of "Buy" from the fourteen research firms that are covering the firm, Marketbeat.com reports. One analyst has...

Xenon Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:XENE)

Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) saw some unusual options trading on Wednesday. Stock traders acquired 4,063 put options on the stock. This represents an increase of 2,362...

Campbell & CO Investment Adviser LLC Takes Position in Xenon Pharmaceuticals Inc. $XENE

Campbell & CO Investment Adviser LLC purchased a new position in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) in the third quarter, according to the company in its most recent...

Xenon Pharmaceuticals (NASDAQ:XENE) Hits New 12-Month High - Time to Buy?

Xenon Pharmaceuticals (NASDAQ:XENE) Reaches New 12-Month High - Still a Buy...

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Current Price	$44.58
Prev Close	$44.79
Open	$45.00
Dividend Yield	0.00%
50-Day Moving Average	$42.51
Beta	0.79
Avg. Volume	1.06M
PE Ratio	-11.53

52-Week High	$46.60
52-Week Low	$26.74
Market Capitalization	$3.46B
EPS (Annual)	-$3.01
Price to Book	6.17
Revenue Per Employee	$0.00

XENE
Xenon Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest XENE News

XENEXenon Pharmaceuticals Inc